Page 3 - Jun Bao News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jun bao. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jun Bao Today - Breaking & Trending Today
SHANGHAI, March 14, 2022 /PRNewswire/ IMPACT Therapeutics, a biopharmaceutical company dedicated to the discovery and development of targeted anti- ....
IMPACT Therapeutics Appoints Dr. Chun-Pyn Shen as Head of Regulatory Affairs prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
IMPACT Therapeutics Appoints Dr. Chun-Pyn Shen as Head of Regulatory Affairs prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Burning Rock and IMPACT Therapeutics Announce a Global Strategic Partnership for Companion . Burning Rock Biotech LimitedAugust 3, 2021 GMT GUANGZHOU, China, Aug. 03, 2021 (GLOBE NEWSWIRE) Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced a global strategic partnership with IMPACT Therapeutics in companion diagnostics (CDx) development for a pipeline of drugs in the field of synthetic lethality. The two companies will jointly develop CDx for a targeted oncology drug, Senaparib (IMP4297), a PARP inhibitor, for the treatment of prostate cancer globally, including CDx submissions to both the U.S. Food and Drug Administration (FDA) and the National Medical Products Administration of China (NMPA). The global program will be supported by Burning Rock’s Clinical Laboratory Improvement Amendments (CLIA) certified and College of Am ....